Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Efficacy and Safety Study of Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia

NCT02260648 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02260648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02260648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Efficacy and Safety Study of Evacetrapib in Combination With Atorvastatin in Japanese Patients With Primary Hypercholesterolemia
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2015
Completion date
November 30, 2015
Enrollment
149 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia